Drug-resistant strains of TB are on the rise, accounting for an estimated 558,000 new cases in 2017 alone. Treatment for MDR-TB can be long, comes with side effects that are difficult for patients to endure, and is expensive. WHO estimates show that only one in four people needing treatment for MDR-TB actually receive it and only half of those treated are cured.
Patients recruited across 12 sites in seven countries for Stage 2 of STREAM clinical trial
People educated through 18,000 health talks delivered by 1,000 community volunteers in Myanmar
Participants from 33 countries attended eight Union courses on MDR-TB in seven countries